CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) | 3 Months Ended | 6 Months Ended | 12 Months Ended | |||
|---|---|---|---|---|---|---|
Jun. 30, 2011 | Jun. 30, 2010 | Jun. 30, 2011 | Jun. 30, 2010 | Dec. 31, 2010 | Dec. 31, 2009 | |
| Revenues | ||||||
| Sales | $ 1,394,294 | $ 1,147,219 | $ 2,759,907 | $ 1,210,479 | $ 3,787,935 | $ 226,212 |
| Royalties | 115,474 | 123,098 | 1,839,972 | |||
| Total revenues | 1,394,294 | 1,147,219 | 2,759,907 | 1,325,953 | 3,911,033 | 2,066,184 |
| Cost of revenues | ||||||
| Cost of sales | 639,227 | 685,278 | 1,284,611 | 700,215 | 1,799,352 | 58,690 |
| Cost of royalties | (189,380) | (186,402) | 400,115 | |||
| Total cost of revenues | 639,227 | 685,278 | 1,284,611 | 510,835 | 1,612,950 | 458,805 |
| Gross profit | 755,067 | 461,941 | 1,475,296 | 815,118 | 2,298,083 | 1,607,379 |
| Operating expenses | ||||||
| Salaries and wages | 733,410 | 664,750 | 1,459,473 | 1,286,951 | 2,750,014 | 2,183,082 |
| Consulting expenses | 298,751 | 119,404 | 635,233 | 195,501 | 793,591 | 235,929 |
| Professional fees | 213,230 | 401,718 | 450,151 | 587,125 | 1,106,626 | 709,479 |
| Research, development, trials and studies | 42,107 | 156,407 | 102,053 | 220,898 | 415,633 | 227,490 |
| General and administrative expenses | 705,547 | 679,494 | 1,549,091 | 1,145,181 | 2,635,145 | 1,700,863 |
| Total operating expenses | 1,993,045 | 2,021,773 | 4,196,001 | 3,435,656 | 7,701,009 | 5,056,843 |
| Income (loss) from operations | (1,237,978) | (1,559,832) | (2,720,705) | (2,620,538) | (5,402,926) | (3,449,464) |
| Other income (expense) | ||||||
| Interest, net | (121,712) | (274,645) | (372,093) | (275,146) | (798,671) | 9,764 |
| Change in fair value of derivative liabilities | (419,739) | 378,125 | (421,795) | (572,313) | 190,888 | |
| Gain on debt restructuring | 576,677 | 576,677 | ||||
| Other | (3,348) | (3,143) | (53,585) | (7,846) | (28,841) | (10,405) |
| Total other income (expenses) | 451,617 | (697,527) | 529,124 | (704,787) | (1,399,825) | 190,247 |
| Income (loss) before provision for income taxes | (786,361) | (2,257,359) | (2,191,581) | (3,325,325) | (6,802,751) | (3,259,217) |
| Income tax provision | 5,000 | 10,000 | 14,000 | |||
| Net income (loss) | (791,361) | (2,257,359) | (2,201,581) | (3,325,325) | (6,816,751) | (3,259,217) |
| Preferred dividends: | ||||||
| Amortization of beneficial conversion feature on Series D preferred stock | 1,948,155 | 1,948,155 | 1,948,155 | |||
| Net loss to common stockholders | (878,004) | (4,292,247) | (2,374,794) | (5,363,629) | (9,039,974) | (3,274,168) |
| Loss per common share - | ||||||
| Loss per common share - Basic and diluted | $ (0.02) | $ (0.11) | $ (0.05) | $ (0.14) | $ (0.23) | $ (0.09) |
| Weighted average shares outstanding - | ||||||
| Weighted average shares outstanding - Basic and diluted | 50,588,129 | 37,502,673 | 48,336,096 | 37,388,783 | 38,668,698 | 35,116,049 |
Series A Preferred Stock | ||||||
| Preferred dividends: | ||||||
| Preferred stock | 2,242 | 2,073 | 4,441 | 4,106 | 8,379 | 7,738 |
Series B Preferred Stock | ||||||
| Preferred dividends: | ||||||
| Preferred stock | 1,526 | 1,410 | 3,022 | 2,793 | 5,698 | 7,213 |
Series D Preferred Stock | ||||||
| Preferred dividends: | ||||||
| Preferred stock | $ 82,875 | $ 83,250 | $ 165,750 | $ 83,250 | $ 260,991 | |